Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Receivables (2016 - 2024)

HealthLynked (HLYK) has disclosed Receivables for 9 consecutive years, with $20058.0 as the latest value for Q4 2024.

  • On a quarterly basis, Receivables fell 22.77% to $20058.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $20058.0, a 22.77% decrease, with the full-year FY2024 number at $20058.0, down 49.34% from a year prior.
  • Receivables was $20058.0 for Q4 2024 at HealthLynked, down from $49057.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $1.9 million in Q1 2024 to a low of $20058.0 in Q4 2024.
  • A 5-year average of $305693.0 and a median of $140881.5 in 2020 define the central range for Receivables.
  • Biggest YoY gain for Receivables was 1139.57% in 2023; the steepest drop was 95.33% in 2023.
  • HealthLynked's Receivables stood at $165464.0 in 2020, then soared by 198.53% to $493963.0 in 2021, then increased by 12.54% to $555887.0 in 2022, then tumbled by 95.33% to $25971.0 in 2023, then decreased by 22.77% to $20058.0 in 2024.
  • Per Business Quant, the three most recent readings for HLYK's Receivables are $20058.0 (Q4 2024), $49057.0 (Q3 2024), and $46823.0 (Q2 2024).